Skip to main content

Alx Oncology Holdings Inc

ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810182

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Alx Oncology Holdings Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ALXO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders9799+2
Shares35.9M36.4M+508.3K (+1.4%)
Value$290.7M$348.7M+$58.0M (+20.0%)

New holders (18)

Institutions that held Alx Oncology Holdings Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ALXO in Q3 2022
InstitutionSharesValue% of portfolio
Eventide Asset Management, LLC902,000$8.63M0.17%
Point72 Asset Management, L.P.382,500$3.66M0.02%
Oasis Management Co Ltd.106,746$1.02M0.18%
Dimensional Fund Advisors LP66,473$636.0K0.00%
Marshall Wace, LLP24,177$231.0K0.00%
BNP Paribas Arbitrage, SA17,380$166.3K0.00%
Dynamic Technology Lab Private Ltd16,340$157.0K0.02%
Gsa Capital Partners LLP16,114$154.0K0.02%
Virginia Retirement Systems Et Al15,300$146.4K0.00%
Jane Street Group, LLC15,033$144.0K0.00%
Squarepoint Ops LLC13,615$130.0K0.00%
MetLife Investment Management11,755$112.5K0.00%
Denali Advisors LLC7,500$72.0K0.03%
Zurcher Kantonalbank (Zurich Cantonalbank)5,234$50.0K0.00%
Metropolitan Life Insurance Co1,308$12.5K0.00%
China Universal Asset Management Co., Ltd.382$4.00K0.00%
Wipfli Financial Advisors LLC,359$3.00K0.00%
US Bancorp65$1.00K0.00%

Sold out (16)

Institutions that held Alx Oncology Holdings Inc at the end of Q2 2022 and filed for Q3 2022 without it.